Social Responsibility

Former Gastro to lead the board of Hepatitis Australia

Health Industry Hub | January 20, 2020 |
[Total: 0    Average: 0/5]

Hepatitis Australia has appointed Associate Professor Grant Phelps as its new President, after Felicity McNeill PSM stepped down from the role in November last year.

Grant worked for many years as a Gastroenterologist, establishing Victoria’s first regionally based liver clinic in Ballarat. More recently he has moved to healthcare management, leadership and consulting roles at organisational and system levels with a focus on clinical leadership for safe, high quality care.

On his appointment Grant said, “I’m excited about leading the Board of Hepatitis Australia, recognising that much good work has been done to change how we treat and support people with hepatitis C, but that much remains to be done, particularly for people with hepatitis B.”

Grant has an academic appointment at Deakin University as Associate Professor of Clinical Leadership, believing that clinicians must work together with their patients and community to lead continual improvements in healthcare services.

Enhance your business visibility, optimise reach and differentiate your brand. Health Industry Hub is the only one-stop-hub connecting your business to Australia’s Pharma, MedTech, and Biotech industry professionals. Get started with our unique media solutions.

Grant also brings significant governance, management and leadership experience to this role. He looks forward to supporting the ongoing development of Hepatitis Australia as the national peak body, while also ensuring the organisation continues to work effectively with its stakeholders and jurisdictional members.

“I would like to acknowledge the work of Helen Tyrrell, the retiring CEO of Hepatitis Australia, who has contributed immensely over many years, and I look forward to working with a new CEO as Hepatitis Australia makes this important appointment in the coming months.”

Grant’s familiarity with all aspects of the health system will be highly beneficial to the work Hepatitis Australia is looking to undertake over the next couple of years. He will be a valuable asset as the organisation continues to push for greater uptake of hepatitis C cures and forges an effective community level response to hepatitis B in Australia.

Hepatitis Australia acknowledges and thanks Felicity McNeill for her leadership and important contributions made during 2018 and 2019. Felicity’s passion and insights into Australia’s health system, particularly the Pharmaceutical Benefits Scheme, have been invaluable and have facilitated effective, ongoing relationships with government.

You may also like Myeloma New Zealand calls on Pharmac to make good on access deal

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Medical

Medical News - Paramedics Association concerned over uni students being thrown in to COVID-19 frontline

Paramedics Association concerned over uni students being thrown in to COVID-19 frontline

Health Industry Hub | April 1, 2020 |

The Australian Paramedics Association NSW (APA(NSW)) has significant concerns for the safety of patients, Paramedics and university students after NSW […]

More


News & Trends - Medical Technology

MedTech News - Australia's private hospitals join the COVID-19 fight in new partnership

Australia’s private hospitals join the COVID-19 fight in new partnership

Health Industry Hub | April 1, 2020 |

A new partnership with the Commonwealth Government will guarantee the viability of Australia’s private hospital sector, ensuring its full capacity […]

More


News & Trends - Pharmaceuticals

Pharma News - Roche's adjuvant treatment PBS listed in early breast cancer

Roche’s adjuvant treatment PBS listed in early breast cancer

Health Industry Hub | April 1, 2020 |

Effective 1st April 2020, Roche’s Kadcyla is listed on the Pharmaceutical Benefits Scheme (PBS), for the adjuvant treatment of patients […]

More


Leadership & Management

Leadership & Management - Bill Gates's insights on COVID-19 global pandemic

Bill Gates’s insights on COVID-19 global pandemic

Health Industry Hub | April 1, 2020 |

In a recent TED Talk, philanthropist and Microsoft co-founder Bill Gates offers insights into the COVID-19 pandemic, discussing why testing […]

More